about
Cytokine responses to novel antigens in a peri-urban population in Brazil exposed to Leishmania infantum chagasi.Leishmania chagasi T-cell antigens identified through a double library screenTh1 Platform Immune Responses Against Leishmania major Induced by Thiol-Specific Antioxidant-Based DNA VaccinesThe role of inflammatory, anti-inflammatory, and regulatory cytokines in patients infected with cutaneous leishmaniasis in Amazonas State, Brazil.Heterologous priming-boosting with DNA and modified vaccinia virus Ankara expressing tryparedoxin peroxidase promotes long-term memory against Leishmania major in susceptible BALB/c MiceTrypanosomatid comparative genomics: Contributions to the study of parasite biology and different parasitic diseases.Coencapsulation of CpG oligodeoxynucleotides with recombinant Leishmania major stress-inducible protein 1 in liposome enhances immune response and protection against leishmaniasis in immunized BALB/c miceImmune responses in DNA vaccine formulated with PMMA following immunization and after challenge with Leishmania majorMulticomponent LBSap vaccine displays immunological and parasitological profiles similar to those of Leish-Tec® and Leishmune® vaccines against visceral leishmaniasis.Cloning of a Recombinant Plasmid Encoding Thiol-Specific Antioxidant Antigen (TSA) Gene of Leishmania majorand Expression in the Chinese Hamster Ovary Cell Line.Leishmania donovani infection down-regulates TLR2-stimulated IL-12p40 and activates IL-10 in cells of macrophage/monocytic lineage by modulating MAPK pathways through a contact-dependent mechanism.The role of Montanide ISA 70 as an adjuvant in immune responses against Leishmania major induced by thiol-specific antioxidant-based protein vaccineThe role of LPD-nanoparticles containing recombinant major surface glycoprotein of Leishmania (rgp63) in protection against leishmaniasis in murine model.Construction of a Novel DNA Vaccine Candidate encoding LmSTI1-PpSP42 Fusion Protein from and Against Cutaneous Leishmaniasi
P2860
Q30416865-119E95AB-D723-4B67-BA76-47B84E8406E7Q33258365-DF85B6A3-D0AF-4721-9FBC-4FFDC0A5F5BFQ34068700-2AD8D249-DFFC-4672-AE31-34BF525ACB1CQ34257064-E41A6B82-C202-451C-B72C-3EB9D7F2ED56Q35689200-AC0A8200-71B0-41F8-81F3-131F83CF11ABQ35855383-BF646428-B10D-4543-A82C-561BA2E54BA2Q36539044-5920AB63-6446-41F5-81A6-E6EBB40CE07CQ37053209-E54765A4-89F4-4350-B9AF-C03283C116EFQ37220949-D92CD6DC-2B0A-4E19-B1B1-B7A072A65019Q39278829-E39EE205-6BEA-4219-87BA-1CB9ADCC8F46Q39942052-13AF753A-A5C0-46B3-9BD7-98EC42FFC6C8Q41278156-D5A01D14-666B-49FD-9822-CBD2B6C66DE2Q50054197-CAA51437-93A4-4E1F-897D-F83AC4B0FCB7Q57489047-B74FC157-9E57-47BE-A2BC-812F0AB275B0
P2860
description
2002 nî lūn-bûn
@nan
2002 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Vaccination against Leishmania infections.
@ast
Vaccination against Leishmania infections.
@en
type
label
Vaccination against Leishmania infections.
@ast
Vaccination against Leishmania infections.
@en
prefLabel
Vaccination against Leishmania infections.
@ast
Vaccination against Leishmania infections.
@en
P356
P1476
Vaccination against Leishmania infections.
@en
P2093
P304
P356
10.2174/1568008023340631
P577
2002-10-01T00:00:00Z